Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
238-877-9
Name of the chemical
Talc: Hydrated magnesium silicate
Concentration
N/A
General Information
Revision date
2022-04-21
Product name
VALTREX GRANULES
Product Synonyms
VALTREX ORAL GRANULES 500 MG/G * VALACYCLOVIR HYDROCHLORIDE, FORMULATED
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
EU Classification
Regulation 26/12/2008-27092 as amended Classification in accordance with Regulation 28848 regarding the Classification, Packaging and Labeling of Substances and Preparations 12/11/2013.
2.1 Classification of the substance or mixture
Xn;R21/22
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4
Environmental hazards
Not classified.
2.2 Label elements
Labeling in accordance with Regulation 28848 regarding the Classification, Packaging and Labeling of Substances and Preparations 11/12/2013
Contains
Polyvinylpyrrolidone, Talc, VALACYCLOVIR HYDROCHLORIDE
Signal word
Warning
Hazard statements
H302 Harmful if swallowed.
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P330 Rinse mouth. P301 + P312 IF SWALLOWED: Immediately call the NATIONAL TOXICITY INFORMATION CENTRE AT 114 or a doctor/physician if you feel unwell. P311 Call the NATIONAL TOXICITY INFORMATION CENTRE at 114 or a doctor/physician.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
39,06 % of the mixture consists of component(s) of unknown acute oral toxicity. 98,86 % of the mixture consists of component(s) of unknown acute dermal toxicity. 94,5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 98,86 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 94,66 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
